Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Genrix Bio is an innovative biopharmaceutical company dedicated to developing advanced antibody-based therapies to address unmet clinical needs. Founded in 2015, we leverage cutting-edge antibody drug discovery technologies to create novel monoclonal and bispecific antibodies for autoimmune diseases, infectious diseases, and oncology. With R&D centers in Beijing, Shanghai, and Chongqing, Genrix Bio possesses end-to-end capabil...
Genrix Bio is an innovative biopharmaceutical company dedicated to developing advanced antibody-based therapies to address unmet clinical needs. Founded in 2015, we leverage cutting-edge antibody drug discovery technologies to create novel monoclonal and bispecific antibodies for autoimmune diseases, infectious diseases, and oncology. With R&D centers in Beijing, Shanghai, and Chongqing, Genrix Bio possesses end-to-end capabilities—from antibody discovery and process development to clinical trials and commercialization.

List your booth number for exhibitions, ask us